Long-Term Persistence of Hormonal Adaptations to Weight Loss
The DOI matches its Crossref record; 38 of the 39 references it cites were found in a registry or an index.
Abstract
Background After weight loss, changes in the circulating levels of several peripheral hormones involved in the homeostatic regulation of body weight occur. Whether these changes are transient or persist over time may be important for an understanding of the reasons behind the high rate of weight regain after diet-induced weight loss. Methods We enrolled 50 overweight or obese patients without diabetes in a 10-week weight-loss program for which a very-low-energy diet was prescribed. At baseline (before weight loss), at 10 weeks (after program completion), and at 62 weeks, we examined circulating levels of leptin, ghrelin, peptide YY, gastric inhibitory polypeptide, glucagon-like peptide 1, amylin, pancreatic polypeptide, cholecystokinin, and insulin and subjective ratings of appetite. Results Weight loss (mean [±SE], 13.5±0.5 kg) led to significant reductions in levels of leptin, peptide YY, cholecystokinin, insulin (P Conclusions One year after initial weight reduction, levels of the circulating mediators of appetite that encourage weight regain after diet-induced weight loss do not revert to the levels recorded before weight loss. Long-term strategies to counteract this change may be needed to prevent obesity relapse. (Funded by the National Health and Medical Research Council and others; ClinicalTrials.gov number, NCT00870259.).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hormonal and metabolic changes induced by weight reduction result in elevated appetite and reduced metabolic rate [13][14][15].”
From Nutritional considerations with antiobesity medications (2024) · cites this paper as [13]
In the citing paper
“Weight loss is accompanied by persistent endocrine adaptations30 that increase appetite and decrease satiety31 thereby resisting continued weight loss and conspiring against long-term weight maintenance.”
From Maintenance of Lost Weight and Long-Term Management of Obesity (2018) · cites this paper as [30]
In the citing paper
“studies have shown that the pandemic was associated with weight gain in the general population. 25”
From 5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study (2024) · cites this paper as [25]
In the citing paper
“and to increased appetite. 9-11”
From Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined (2021) · cites this paper as [10]
In the citing paper
“although only 2% of eligible patients are currently receiving therapy [17].”
From Nutritional considerations with antiobesity medications (2024) · cites this paper as [17]
16 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419
Central nervous system control of food intake
Schwartz, M. W., Woods, S. C., Porte, D., Seeley, R. J., & Baskin, D. G. (2000) · Nature · doi:10.1038/35007534 · Cited by 6,451
Serum Immunoreactive-Leptin Concentrations in Normal-Weight and Obese Humans
Considine, R. V., Sinha, M. K., Heiman, M. L., Kriauciunas, A., Stephens, T. W., Nyce, M. R., Ohannesian, J. P., Marco, C. C., McKee, L. J., Bauer, T. L., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602013340503 · Cited by 6,326
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457
Effects of the obese Gene Product on Body Weight Regulation in ob / ob Mice
Pelleymounter, M. A., Cullen, M. J., Baker, M. B., Hecht, R., Winters, D., Boone, T., & Collins, F. (1995) · Science · doi:10.1126/science.7624776 · Cited by 4,017
Long-term mortality after gastric bypass surgery
Adams, T. D., Gress, R. E., Smith, S. C., Halverson, R. C., Simper, S. C., Rosamond, W. D., LaMonte, M. J., Stroup, A. M., & Hunt, S. C. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066603 · Cited by 2,572
Ghrelin enhances appetite and increases food intake in humans
Wren, A. M., Seal, L. J., Cohen, M. A., Brynes, A. E., Frost, G. S., Murphy, K. G., Dhillo, W. S., Ghatei, M. A., & Bloom, S. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.12.8111 · Cited by 2,494
Gut hormone PYY3-36 physiologically inhibits food intake
Batterham, R. L., Cowley, M. A., Small, C. J., Herzog, H., Cohen, M. A., Dakin, C. L., Wren, A. M., Brynes, A. E., Low, M. J., Ghatei, M. A., et al. (2002) · Nature · doi:10.1038/nature00887 · Cited by 2,351
Plasma Ghrelin Levels after Diet-Induced Weight Loss or Gastric Bypass Surgery
Cummings, D. E., Weigle, D. S., Frayo, R. S., Breen, P. A., Ma, M. K., Dellinger, E. P., & Purnell, J. Q. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012908 · Cited by 2,241
Changes in Energy Expenditure Resulting from Altered Body Weight
Leibel, R. L., Rosenbaum, M., & Hirsch, J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503093321001 · Cited by 2,012
Cited by
Items 501–600 of 1,004
Torbahn, G., Lischka, J., Brown, T. J., Ells, L. J., Kelly, A. S., Wabitsch, M., & Weghuber, D. (2024) · Clinical Endocrinology · doi:10.1111/cen.15133 · Cited by 33
Hill, B. R., Rolls, B. J., Roe, L. S., Souza, M. J. D., & Williams, N. I. (2013) · Peptides · doi:10.1016/j.peptides.2013.09.009 · Cited by 33
“Some studies have demonstrated increases [28, 33] whereas others have observed decreases [21, 46, 55] or no change [51] in PYY in response to weight loss.”
BackgroundResultAssociation between serum soluble corin and obesity in C hinese adults: A cross‐sectional study
Peng, H. Y., Zhang, Q., Shen, H., Liu, Y., Chao, X., Tian, H., Cai, X., & Jin, J. (2015) · Obesity · doi:10.1002/oby.21016 · Cited by 29
“, renal artery stenosis, coarctation, glomerulonephritis, pyelonephritis, phaeochromocytoma, Cushing’s syndrome, Conn’s syndrome), (2) self-reported history of coronary heart disease, stroke, or tumors, (3) self-reported thyroid or parathyroid diseases, (4) being pregnant.”
BackgroundMai, K., Li, L., Wiegand, S., Brachs, M., Leupelt, V., Ernert, A., Kühnen, P., Hübner, N., Robinson, P. N., Chen, W., et al. (2018) · Diabetes · doi:10.2337/db18-0440 · Cited by 31
“Although the counter-regulatory neuroendocrine adaption after weight loss may promote weight regain in humans (6), the specific circuits predicting body weight regain in humans are not clear.”
BackgroundIntermittent fasting: What questions should we be asking?
Liu, K., Liu, B., & Heilbronn, L. K. (2020) · Physiology & Behavior · doi:10.1016/j.physbeh.2020.112827 · Cited by 32
Chukir, T., Mandel, L., Tchang, B. G., Al-Mulla, N. A., Igel, L. I., Kumar, R. B., Waitman, J. A., Aronne, L. J., & Shukla, A. P. (2020) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2020.12.005 · Cited by 29
Diabetes Nutrition Therapy: Effectiveness, Macronutrients, Eating Patterns and Weight Management
Franz, M. J. (2016) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2016.02.001 · Cited by 36
Chen, V. P., Gao, Y., Geng, L., & Brimijoin, S. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1706517114 · Cited by 31
“As noted earlier, this mechanism comes into play as soon as weight is lost and persists during weight regain (8).”
BackgroundThe Role of Gut Hormones in Diet-Induced Weight Change: A Systematic Review
Zhao, X., Han, Q., Gang, X., Lv, Y., Liu, Y., Sun, C., & Wang, G. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-115646 · Cited by 29
“Among 16 studies, twelve studies focused on PYY [14, 16, 23, 25, 27–33, 35], eleven studies measured ghrelin [14, 16, 23, 24, 26–32], 7 studies were aimed to GLP-1[14, 16, 28, 33, 34, 36], 4 studies on CCK [14, 24, 26, 29], 4 studies on PP [14, 16, 27, 28, 33], 4 studies on GIP [14, 16, 31, 33], and 2 studies focused…”
BackgroundResultInfluentialZenténius, E., Andersson‐Assarsson, J. C., Carlsson, L. M. S., Svensson, P., & Larsson, I. (2018) · Obesity · doi:10.1002/oby.22200 · Cited by 31
“In addition, changes in appetite and satiety hormones (30) and in thermogenesis (31) induced by the weight loss may hinder long-term weight-loss maintenance.”
BackgroundEnglish, S., & Vallis, M. (2023) · Clinical Obesity · doi:10.1111/cob.12615 · Cited by 28
“When the weight loss trajectory plateaus, due to innate compensatory mechanisms that can make it difficult to keep weight off, 17 the PwO is likely to experience this as a failure.”
BackgroundEvolving Approaches for Pharmacological Therapy of Obesity
Chao, A. M., Taylor, S. I., Moore, M., Amaro, A., & Wadden, T. A. (2024) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-031124-101146 · Cited by 30
The gut sensor as regulator of body weight
Reinehr, T., & Roth, C. L. (2014) · Endocrine · doi:10.1007/s12020-014-0518-1 · Cited by 30
“The most frequently applied methods are the Roux-en-Y gastric bypass operation (RYGB) and a sleeve resection of the stomach, removing two-third of the stomach predominantly on the large curvature.”
InfluentialQuist, J. S., Blond, M. B., Gram, A. S., Steenholt, C. B., Janus, C., Holst, J. J., Rehfeld, J. F., Sjödin, A., Stallknecht, B., & Rosenkilde, M. (2019) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00239.2018 · Cited by 28
Obesity, Metabolic Syndrome and Disorders of Energy Balance
Han, J. C., & Weiss, R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00024-5 · Cited by 30
Obesity: novel and unusual predisposing factors
Hanson, P., Weickert, M. O., & Barber, T. M. (2020) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018820922018 · Cited by 33
An Exploration of the Role of Sugar-Sweetened Beverage in Promoting Obesity and Health Disparities
Sigala, D. M., & Stanhope, K. L. (2021) · Current Obesity Reports · doi:10.1007/s13679-020-00421-x · Cited by 33
Iłowiecka, K., Glibowski, P., Skrzypek, M., & Styk, W. (2021) · Nutrients · doi:10.3390/nu13062020 · Cited by 35
“Primly, the weight loss process leads to metabolic adaptations that promote repeat weight gain [10,11].”
BackgroundLiu, X., Jin, Z., Summers, S., Derous, D., Li, M., Li, B., Li, L., & Speakman, J. R. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110835 · Cited by 29
Once-weekly 2.4 mg Semaglutide for Weight Management in Obesity: A Game Changer?
Colin, I. M., & Gérard, A.-C. (2022) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2022.18.1.35 · Cited by 30
Unhealthy Weight Control Practices: Culprits and Clinical Recommendations
Ferraro, Z. M., Patterson, S., & Chaput, J. (2015) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.4137/cmed.s23060 · Cited by 33
Emerging drugs for the treatment of obesity
Martinussen, C., Bojsen-Møller, K. N., Svane, M. S., Dejgaard, T. F., & Madsbad, S. (2016) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2017.1269744 · Cited by 28
“Adaptive changes in gut hormone secretion may also be involved [20].”
BackgroundPrice, S., & Nankervis, A. J. (2025) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-024-07849-9 · Cited by 32
“Diet-induced weight loss in non-pregnant human adults’ results in a reduction in fasting GLP-1 and an increase in GIP [42].”
The (dys)regulation of energy storage in obesity
Levin, B. E., Geary, N., & Lutz, T. A. (2025) · Physiological Reviews · doi:10.1152/physrev.00002.2024 · Cited by 29
Bad words: why language counts in our work with bariatric patients
Sogg, S., Grupski, A. E., & Dixon, J. B. (2018) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2018.01.013 · Cited by 27
Wood, G. C., Bailey-Davis, L. D., Benotti, P. N., Cook, A., DOVE, J. T., Mowery, J., Ramasamy, A., Iyer, N. N., Smolarz, B. G., Kumar, N., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0258545 · Cited by 28
An Updated Approach to Antiobesity Pharmacotherapy: Moving Beyond the 5% Weight Loss Goal
Enright, C., Thomas, E., & Saxon, D. R. (2023) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac195 · Cited by 32
“Because these changes persist after weight loss, lifestyle interventions often need to be augmented by therapies such as AOMs and bariatric surgery that target these compensatory mechanisms [23].”
Hemmingsson, E., Väisänen, D., Andersson, G. B. J., Wallin, P., & Ekblom‐Bak, E. (2021) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwab169 · Cited by 32
Young, M. D., Callister, R., Collins, C. E., Plotnikoff, R. C., Aguiar, E. J., & Morgan, P. J. (2017) · Obesity · doi:10.1002/oby.21696 · Cited by 26
“Given the substantial challenges associated with long-term WLM (35,36), this suggests that future programs may require more support or a greater frequency and/or duration of contact during WLM to encourage men to engage with all program components.”
BackgroundHagan, S., & Nelson, K. (2023) · Journal of General Internal Medicine · doi:10.1007/s11606-022-07821-w · Cited by 26
“The mechanisms of this complex, long-term defense include metabolic adaptation, in which energy expenditure decreases more than expected from weight change alone,(43,44) and increased hunger hormone signaling leading to an increased drive to eat.(45) These defenses promote positive energy balance, leading to weight re…”
BackgroundTime to weight plateau with tirzepatide treatment in the SURMOUNT ‐1 and SURMOUNT ‐4 clinical trials
Horn, D. B., Kahan, S., Batterham, R. L., Cao, D., Lee, C. J., Murphy, M., Gonsahn‐Bollie, S., Chigutsa, F., Stefanski, A., & Dunn, J. P. (2025) · Clinical Obesity · doi:10.1111/cob.12734 · Cited by 25
Role of Ghrelin in the Pathophysiology of Eating Disorders: Implications for Pharmacotherapy
Cano, S. C., Merkestein, M., Skibicka, K. P., Dickson, S. L., & Adan, R. A. H. (2012) · CNS Drugs · doi:10.2165/11599890-000000000-00000 · Cited by 27
Sargeant, J. A., King, J. A., Yates, T. E., Baldry, E. L., Bodicoat, D. H., Chatterjee, S., Edwardson, C. L., Gray, L. J., Poulin, B., Waheed, G., et al. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14721 · Cited by 29
“Moderate-to-vigorous-intensity physical activity (min/d) 17 (10-37) 16 (8-37) 15 (11-25) 19 (5-46)”
InfluentialLong-Term Persistence of Hormonal Adaptations to Weight Loss
Oetjen, E. (2012) · Yearbook of Endocrinology · doi:10.1016/j.yend.2012.03.060 · Cited by 26
Obesity in adults: Clinical practice guideline adapted for Chile
de la Obesidad, C. C. P. E. E., & Contreras, Y. P. (2022) · Medwave · doi:10.5867/medwave.2022.10.2649 · Cited by 31
Liraglutide versus semaglutide for weight reduction—a cost needed to treat analysis
Azuri, J., Hammerman, A., Aboalhasan, E., Sluckis, B., & Arbel, R. (2023) · Obesity · doi:10.1002/oby.23752 · Cited by 27
“The traditional mainstay of management is lifestyle modifications, but long-term outcomes for sustained weight loss are poor [1, 2, 8, 9].”
BackgroundGastrointestinal Hormones and Weight Loss Maintenance Following Roux-en-Y Gastric Bypass
de Hollanda, A., Casals, G., Delgado, S., Jiménez, A., Viaplana, J., Lacy, A. M., & Vidal, J. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3065 · Cited by 26
2-Year BMI Changes of Children Referred for Multidisciplinary Weight Management
Cheng, J. K., Wen, X., Coletti, K., Cox, J. E., & Taveras, E. M. (2014) · International Journal of Pediatrics · doi:10.1155/2014/152586 · Cited by 26
“found that circulating levels of leptin, peptide YY, cholecystokinin, insulin, ghrelin, gastric inhibitory polypeptide, and pancreatic polypeptide, as well as subjective feelings of hunger, do not revert to the preweight loss levels even one year after initial weight reduction [9].”
BackgroundCall for an urgent rethink of the ‘health at every size’ concept
Sainsbury, A., & Hay, P. (2014) · Journal of Eating Disorders · doi:10.1186/2050-2974-2-8 · Cited by 30
“calorie diets (VLCDs), which appear to instil long-lasting increases in appetite [17], a sign of the body defending”
BackgroundLifestyle Interventions to Reduce Obesity and Diabetes
Hagobian, T. A., & Phelan, S. (2012) · American Journal of Lifestyle Medicine · doi:10.1177/1559827612449600 · Cited by 29
Versteeg, R. I., Schrantee, A., Adriaanse, S. M., Unmehopa, U. A., Booij, J., Reneman, L., Fliers, E., la Fleur, S. E., & Serlie, M. J. M. (2017) · The FASEB Journal · doi:10.1096/fj.201601234r · Cited by 35
“Afterweight loss, long-termchanges in circulating appetite-related signals such as leptin, ghrelin, and peptide YY promote food intake favoring subsequent weight regain (3).”
Biology of obesity and weight regain: Implications for clinical practice
Rogge, M. M., & Gautam, B. (2017) · Journal of the American Association of Nurse Practitioners · doi:10.1002/2327-6924.12504 · Cited by 29
“Alterations in hypothalamic energy signaling and the decreased energy expenditure have been shown to persist for years, or until the weight is regained (Rosenbaum et al., 1997; Sumithran et al., 2011).”
BackgroundPrevention and Treatment of Type 2 Diabetes: A Pathophysiological-Based Approach
Samocha‐Bonet, D., Debs, S. R., & Greenfield, J. R. (2018) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2018.03.014 · Cited by 29
Devices and Endoscopic Bariatric Therapies for Obesity
Saunders, K. H., Igel, L. I., Saumoy, M., Sharaiha, R. Z., & Aronne, L. J. (2018) · Current Obesity Reports · doi:10.1007/s13679-018-0307-x · Cited by 26
Ostendorf, D. M., Melanson, E. L., Caldwell, A. E., Creasy, S. A., Pan, Z., MacLean, P. S., Wyatt, H. R., Hill, J. O., & Catenacci, V. A. (2018) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqy179 · Cited by 25
“Although strong biological pressures toward weight regain after weight loss have been identified (35, 36), our case-control study suggests that a substantial, disproportionately lower REE than predicted may not be a universal part of the biological pressure to regain weight after weight loss in all humans.”
ResultKokkinos, A. D., Tsilingiris, D., le Roux, C. W., Rubino, F., & Mantzoros, C. S. (2019) · Metabolism · doi:10.1016/j.metabol.2019.153960 · Cited by 29
Morante, J. J. H., Soler, I. D., Muñoz, J. S. G., Pérez‐Sánchez, H., Ortega, M. D. C. B., Martínez, C. M., & Ruiz, J. M. M. (2020) · Nutrients · doi:10.3390/nu12040916 · Cited by 29
“Despite the strong evidence asserting the biological adaptations of leptin and ghrelin after weight loss, which increase the propensity for weight regain [54], their changes, taken alone, are not sufficient modulators of the homeostatic regulation of appetite [38].”
BackgroundReview of 3‐year outcomes of a very‐low‐energy diet‐based outpatient obesity treatment programme
Sumithran, P., Prendergast, L. A., Haywood, C. J., Houlihan, C. A., & Proietto, J. (2016) · Clinical Obesity · doi:10.1111/cob.12135 · Cited by 27
“The treatment programme is based on the following premises: the predisposition to obesity has a genetic and/or epigenetic basis (4,5); body weight is physiologically defended (6-8); a very-low-energy diet (VLED) is more effective than a hypocaloric balanced diet for initial weight loss (3, 9); over the long-term, weig…”
InfluentialSelf-citationPerspectives in weight control in diabetes - survodutide
Klein, T., Augustin, R., & Hennige, A. M. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110779 · Cited by 25
Survodutide Once Weekly for the Treatment of Adults with Obesity
le Roux, C. W., Wharton, S., Startseva, E., Kloer, I. M., Hussain, S. A., Unseld, A., Bozkurt, B., Ard, J. D., Bays, H. E., Bogdański, P., et al. (2026) · New England Journal of Medicine · doi:10.1056/nejmoa2600751 · Cited by 33
Pérez-Rodríguez, M., Huertas, J. R., Villalba, J. M., & Casuso, R. A. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155336 · Cited by 27
Pediatric Obesity Pharmacotherapy: State of the Science, Research Gaps, and Opportunities
Armstrong, S., Eneli, I., Osganian, S. K., Wagner, B. E., Waldrop, S., & Kelly, A. S. (2024) · PEDIATRICS · doi:10.1542/peds.2024-067858 · Cited by 31
mTOR and regulation of energy homeostasis in humans
Mannaa, M., Krämer, S., Boschmann, M., & Gollasch, M. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1057-6 · Cited by 28
Price, S., Nankervis, A. J., Permezel, M., Prendergast, L. A., Sumithran, P., & Proietto, J. (2018) · Trials · doi:10.1186/s13063-018-2615-6 · Cited by 25
“• We accept pre-submission inquiries • Our selector tool helps you to find the most relevant journal • We provide round the clock customer support • Convenient online submission • Thorough peer review • Inclusion in PubMed and all major indexing services • Maximum visibility for your research Submit your manuscript at…”
MethodResultInfluentialSelf-citationSima, E., Webb, D.-L., Hellström, P. M., & Sundbom, M. (2019) · Obesity Surgery · doi:10.1007/s11695-019-04089-8 · Cited by 25
Obesity and Type 2 Diabetes Mellitus
Sharma, A. M., & Lau, D. C. W. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.03.360 · Cited by 25
Dash, S. (2024) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15829 · Cited by 24
Appetite-related Gut Hormone Responses to Feeding Across the Life Course
Holliday, A., Horner, K. M., Johnson, K. O., Dagbasi, A., & Crabtree, D. R. (2025) · Journal of the Endocrine Society · doi:10.1210/jendso/bvae223 · Cited by 26
Fitch, A., & Ingersoll, A. B. (2020) · Postgraduate Medicine · doi:10.1080/00325481.2020.1845534 · Cited by 26
“lifestyle modifications tend not to yield meaningful reductions in weight in the long term [23,24].”
BackgroundMyokines in Appetite Control and Energy Balance
Grannell, A., Kokkinos, A. D., & le Roux, C. W. (2022) · Muscles · doi:10.3390/muscles1010003 · Cited by 25
“In response to FM loss, reductions in leptin are detected by the central nervous system, leading to a decrease in energy expenditure [10] and an increase in hunger [11].”
BackgroundHernando‐Redondo, J., Toloba, A., Benaiges, D., Salas‐Salvadó, J., Martínez‐González, M. Á., Corella, D., Estruch, R., Tinahones, F. J., Ros, E., Goday, A., et al. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.950900 · Cited by 27
“Higher circulating levels have been observed in short-term, with lesser evidence after 1 year of initial weight loss (13).”
BackgroundAlves, R. D. M., de Oliveira, F. C. E., Hermsdorff, H. H. M., Abete, I., Zulet, M. Á., Martínez, J. A., & Bressan, J. (2013) · European Journal of Nutrition · doi:10.1007/s00394-013-0497-7 · Cited by 25
Stubbs, R. J. (2012) · The Open Obesity Journal · doi:10.2174/1876823701204010035 · Cited by 32
“This is interesting because it may be that weight loss induces changes in physiology that pose a challenge for weight loss maintenance [37-42].”
BackgroundInfluentialBariatric Surgery: A Perspective for Primary Care
Kizy, S., Jahansouz, C., Wirth, K. M., Ikramuddin, S., & Leslie, D. B. (2017) · Diabetes Spectrum · doi:10.2337/ds17-0034 · Cited by 28
“In contrast, a reduction in peptide YY is observed after weight loss resulting from caloric restriction (54).”
BackgroundSchnebelen, C., Négro, N., Jaruga, A., Roques, C.-F., & Lecerf, J. (2019) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2019.06.005 · Cited by 27
Dinu, M., Colombini, B., Pagliai, G., Cesari, F., Gori, A. M., Giusti, B., Marcucci, R., & Sofi, F. (2019) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2019.1658723 · Cited by 27
“Thus, ghrelin levels are expected to increase under conditions of caloric restriction and weight loss (Cummings 2006; Sumithran et al. 2011).”
BackgroundPharmacological profile of once-weekly injectable semaglutide for chronic weight management
Lau, D. C. W., Batterham, R. L., & le Roux, C. W. (2022) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2022.2070473 · Cited by 27
Adaptations to a diet‐based weight‐reducing programme in obese women resistant to weight loss
Tremblay, A., Page, C. L., Panahi, S., Couture, C., & Drapeau, V. (2015) · Clinical Obesity · doi:10.1111/cob.12094 · Cited by 25
“Recent data suggest that changes in appetite sensations and related hormonal variables persist as long as a weight-reduced obese state is maintained (13).”
BackgroundBeyond Glucose—Rethinking Prediabetes for Precision Prevention
Wagner, R. J., Selvin, E., Sehgal, R., Prystupa, K., Misra, S., Fritsche, A., & Heni, M. (2025) · Diabetes Care · doi:10.2337/dci25-0054 · Cited by 30
Insights into the Mechanism of Action of Tirzepatide: A Narrative Review
Galindo, R. J., CHENG, A. Y. Y., Longuet, C., Ai, M., Coşkun, T., Malik, R., Peleshok, J. C., Levine, J. A., & Dunn, J. P. (2025) · Diabetes Therapy · doi:10.1007/s13300-025-01804-w · Cited by 32
“…weight reduction is achieved by caloric restriction alone, increases in appetite caused by weight loss-induced modifications in neuroendocrine hormones that regulate hunger (increased ghrelin), satiety (decreased peptide YY, amylin), and fullness (decreased cholecystokinin) would be expected [66].”
OTT-FONTES, P. R., Neto, J. A. D., & Goldoni, M. B. (2020) · Revista do Colégio Brasileiro de Cirurgiões · doi:10.1590/0100-6991e-20202485 · Cited by 25
Barrea, L., Salzano, C., Pugliese, G., Laudisio, D., Frías-Toral, E., Savastano, S., Colao, A., & Muscogiuri, G. (2022) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2022.2130186 · Cited by 24
“Several studies reported no association between leptin reductions during weight loss and subsequent weight change (Wing et al. 1996; Vogels and Westerterp-Plantenga 2007; Sumithran et al. 2011), while others reported opposite results (Mavri et al. 2001; Crujeiras et al. 2010).”
BackgroundMethodResultInfluentialPosovszky, C., & Wabitsch, M. (2015) · Hormone Research in Paediatrics · doi:10.1159/000369555 · Cited by 25
Stubbs, R. J., & Turicchi, J. (2021) · Obesity Reviews · doi:10.1111/obr.13191 · Cited by 25
“2%.(122) Nymo et al(123) also showed an increase in hunger over 12 months after 15% WL induced by a VLCD.”
BackgroundCombination phentermine and topiramate for weight maintenance: the first Australian experience
Neoh, S. L., Sumithran, P., Haywood, C. J., Houlihan, C. A., Lee, F., & Proietto, J. (2014) · The Medical Journal of Australia · doi:10.5694/mja13.00193 · Cited by 26
Self-citationAnti-obesity drug therapy in clinical practice: Evidence of a poor prescriptive attitude
Squadrito, F., Rottura, M., Irrera, N., Minutoli, L., Bitto, A., Barbieri, M. A., Cicala, G., Mecchio, A., Pallio, G., Marino, S., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110320 · Cited by 22
Leptin and energy restriction induced adaptation in energy expenditure
Camps, S. G. J. A., Verhoef, S. P. M., & Westerterp, K. R. (2015) · Metabolism · doi:10.1016/j.metabol.2015.06.016 · Cited by 22
“[19] Sumithran P, Prendergast LA, Delbridge E, Purcell K, Shulkes A, Kriketos A, et al.”
BackgroundObesity-associated deterioration of the hippocampus is partially restored after weight loss
Liśkiewicz, A., Liśkiewicz, D., Marczak, Ł., Przybyła, M., Grabowska, K., Student, S., Dębiec, M., Sługocka, A., & Lewin‐Kowalik, J. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.05.030 · Cited by 26
Designation of Obesity as a Disease: Lessons Learned From Alcohol and Tobacco
Hurt, R. T., Varayil, J. E., Mundi, M. S., Martindale, R. G., & Ebbert, J. O. (2014) · Current Gastroenterology Reports · doi:10.1007/s11894-014-0415-z · Cited by 26
Lee, K., Clarke, I. J., John, J. C. S., Young, I. R., Leury, B. J., Rao, A., Andrews, Z. B., & Henry, B. A. (2013) · The FASEB Journal · doi:10.1096/fj.13-238345 · Cited by 23
Current and Emerging Pharmacotherapies for Weight Management in Prediabetes and Diabetes
Lau, D. C. W., & Teoh, H. (2015) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2015.10.001 · Cited by 26
“Finally, weight regain can result from the compensatory response to hormonal and metabolic changes following initial weight loss, where orexigenic mediators that stimulate appetite persist (15).”
BackgroundInfluentialCurrent Perspectives on Long-term Obesity Pharmacotherapy
Wharton, S. (2015) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2015.07.005 · Cited by 30
DerSarkissian, M., Bhak, R. H., Huang, J., Buchs, S., Vekeman, F., Smolarz, B. G., Brett, J., Ganguly, R., & Duh, M. S. (2017) · Current Medical Research and Opinion · doi:10.1080/03007995.2017.1307173 · Cited by 22
Philosophical determinants of obesity as a disease
Kilov, D., & Kilov, G. (2017) · Obesity Reviews · doi:10.1111/obr.12597 · Cited by 24
“In addition to reduced energy expenditure, levels of the hunger hormone ghrelin are raised (23), while satiety hormones such as amylin, PYY and cholecystokinin are suppressed (24).”
BackgroundTang, T., Abbott, S., le Roux, C. W., Wilson, V., Singhal, R., Bellary, S., & Tahrani, A. A. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13131 · Cited by 25
“In other individuals who respond well to lifestyle interventions or pharmacotherapy, bariatric surgery will still aid further weight loss and the preoperative weight loss in these individuals seems to predict greater overall weight loss; in these individuals, bariatric surgery will still counteract the usual metabolic…”
BackgroundPharmacotherapy for obesity in individuals with type 2 diabetes
Chukir, T., Shukla, A. P., Saunders, K. H., & Aronne, L. J. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1428558 · Cited by 22
“The use of adjunctive pharmacotherapies and/or weight loss surgery is a strategy to counteract these mechanisms and achieve durable weight loss [9].”
BackgroundMethodEffect of Testosterone Treatment on Adipokines and Gut Hormones in Obese Men on a Hypocaloric Diet
Ng Tang Fui, M., Hoermann, R., & Grossmann, M. (2017) · Journal of the Endocrine Society · doi:10.1210/js.2017-00062 · Cited by 22
“These changes persisted at week 56 despite 46 weeks of weight maintenance, confirming and extending previous findings [15].”
BackgroundResultInfluentialCheng, H. L., Sainsbury, A., Garden, F. L., Sritharan, M., Paxton, K., Luscombe, G. M., Hawke, C. I., & Steinbeck, K. S. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01825 · Cited by 22
Physiological Predictors of Weight Regain at 1‐Year Follow‐Up in Weight‐Reduced Adults with Obesity
Nymo, S., Coutinho, S. R., Rehfeld, J. F., Truby, H., Kulseng, B. E., & Martins, C. (2019) · Obesity · doi:10.1002/oby.22476 · Cited by 25
“However, they reported no significant correlations between the increase in appetite (either subjective appetite feelings or plasma concentration of AG, CCK, total PYY, active GLP-1, and insulin) seen with WL and weight regain at 1-year follow-up in their Supporting Information (6).”
BackgroundResultInfluentialThe role of gut hormones in the pathogenesis and management of obesity
Makaronidis, J., & Batterham, R. L. (2019) · Current Opinion in Physiology · doi:10.1016/j.cophys.2019.04.007 · Cited by 26
The Fight Against Obesity Escalates: New Drugs on the Horizon and Metabolic Implications
Tsilingiris, D., Liatis, S., Dalamaga, Μ., & Kokkinos, A. D. (2020) · Current Obesity Reports · doi:10.1007/s13679-020-00378-x · Cited by 23
Flack, K. D., Hays, H. M., & Moreland, J. (2020) · PLoS ONE · doi:10.1371/journal.pone.0234692 · Cited by 23
Staniorski, C., & Rusilko, P. J. (2021) · Translational Andrology and Urology · doi:10.21037/tau-20-1232 · Cited by 22
“These modest results are difficult to maintain as many in this study experienced gradual weight regain and biochemical studies have even shown the appetite stimulating hormones often revert back to pre-weight loss levels and make sustaining these changes difficult (25,26).”
ResultHedonik Açlık ve Yeme Davranışı İlişkisinin Farklı Beden Kütlelerine Yansıması
Ayyıldız, F., Ülker, İ., & Yıldıran, H. (2021) · Journal of Nutrition and Dietetics · doi:10.33076/2021.bdd.1465 · Cited by 29
“org/0000-0001-7956-5087 Bes Diy Derg 2021;49(2):9-17”
Adipocytes control food intake and weight regain via Vacuolar-type H+ ATPase
Zapata, R. C., Carretero, M., Reis, F. C. G., Chaudry, B. S., Ofrecio, J. M., Zhang, D., Šášik, R., Ciaraldi, T. P., Petrascheck, M., & Osborn, O. (2022) · Nature Communications · doi:10.1038/s41467-022-32764-5 · Cited by 25
Physiology, pathophysiology and therapeutic implications of enteroendocrine control of food intake
Elliott, J. A., Reynolds, J. V., le Roux, C. W., & Docherty, N. G. (2016) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2016.1245140 · Cited by 23
“The observed changes in leptin, insulin, PYY, CCK, and ghrelin persisted at 1 year [52].”
BackgroundNatural Dietary Products and Their Effects on Appetite Control
Suh, J. H., Wang, Y., & Ho, C. (2017) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b05104 · Cited by 22
Obesity is a chronic progressive relapsing disease of particular interest for internal medicine
Sbraccia, P., & Dicker, D. (2022) · Internal and Emergency Medicine · doi:10.1007/s11739-022-03129-z · Cited by 23
“The set of these regulatory mechanisms comes into play powerfully when weight is intentionally lost: the body senses the threat of energy deprivation (regardless of the benefit to which it leads) and triggers a hormonal and neurotransmitter counter-reaction which, in association with the reduction of energy expenditur…”
BackgroundTham, K. W., Ahmed, A., Boonyavarakul, A., Garcia, M. M., Guajardo, M., Hanipah, Z. N., Nam, T. Q., Nicodemus, N. A., Pathan, F., Romano, J. G. U., et al. (2024) · Clinical Obesity · doi:10.1111/cob.12644 · Cited by 21
“…understanding, through better education, of the chronic disease status of obesity and the adaptive physiological changes at play that make WL and maintenance of WL extremely difficult, 16 – 18 should help dispel judgements of HCPs and others of PwO as unmotivated in their attempts to lose weight.”
BackgroundPhysiological Appetite Regulation and Bariatric Surgery
Ramasamy, I. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13051347 · Cited by 27
“Weight loss due to a low calorie diet results in significant reductions in levels of leptin, PYY, CCK amylin, and insulin and increases in levels of ghrelin, GIP, and PP [220].”
Background
Metadata
- Authors
- Sumithran, P., Prendergast, L. A., Delbridge, E., Purcell, K., Shulkes, A., Kriketos, A., & Proietto, J.
- Affiliations
- The University of Melbourne (AU)
- La Trobe University (AU)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2011-10-27
- Volume
- 365
- Issue
- 17
- Pages
- 1597-1604
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2167222546
- Semantic Scholar
- 3a76a35458f699a743f3d47b276f2fea2ca1d1c0
- Cited by
- 1,449
- References
- 39
- Citations by year
- 2026: 128 · 2025: 98 · 2024: 97 · 2023: 99 · 2022: 104 · 2021: 109 · 2020: 104 · 2019: 92 · 2018: 101 · 2017: 101 · 2016: 86 · 2015: 79 · 2014: 78 · 2013: 95 · 2012: 75
- FWCI
- 37.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Keywords
- weight loss, hormonal adaptation, appetite, leptin, ghrelin, peptide YY, cholecystokinin, glucose-dependent insulinotropic polypeptide, pancreatic polypeptide, amylin, glucagon-like peptide-1, insulin, very low calorie diet, weight regain
- MeSH terms
- Body Weight, Cholecystokinin, Diet, Reducing, Female, Gastrointestinal Hormones, Humans, Male, Middle Aged, Obesity, Peptides, Weight Loss, Body Mass Index, Postmenopause, Peptide YY, Leptin, Glucagon-Like Peptide 1, Ghrelin, Intention to Treat Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.